Episode Details

Back to Episodes
142 - Allison Duettmann President & CEO: Neurotech Series - Foresight Institute, Existential Hope

142 - Allison Duettmann President & CEO: Neurotech Series - Foresight Institute, Existential Hope

Episode 142 Published 3 years, 3 months ago
Description

Let us know your thoughts. Send us a Text Message.

Follow me to see #HeadsTalk Podcast Audiograms every Monday on LinkedIn

Episode Title:- 🇺🇸Existential Hope🇺🇸

My #HTNeurotechSeries HeadsTalk guest today is the leader of an organisation dedicated to the development of high-impact technologies that are focused on several fields of Science. From molecular nanotechnology, to brain-computer interfaces, space exploration, cryptocommerce, and AI. 

Allison Duettmann is the President and CEO of Foresight Institute and our conversation focused on the work that she and her team are doing.  

Foresight Institute has been around since 1986 and Allison within the organisation for 11 years.  She directs the:

  • Intelligent Cooperation
  • Molecular Machines
  • Biotech & Health Extension
  • Neurotech & Space Groups
  • Fellowships, Prizes; and Tech Trees

Allison not only shares the work of Foresight with the public, but has had a number of media appearances and done speeches on various topics relating to AI, Computing and Technology development.  

Topics Covered:
◽️ Work of FI
◽️ Up and Coming Workshops and Events
◽️ Neuroscience, AI and ML Today and Tomorrow
◽️ Existential Hope Concept

So download⏳grab a cup of Bird & Blend Tea Co - Smoky Russian Tea ☕️& have a listen🛋

Series Sponsored by - PrivCap Resource Group
Series Partnered with Foresight Institute

Existentialhope.com
Gaming the Future

Next week's guest announced on LinkedIn every Monday. Follow me to see.

ABOUT THE HOST
HeadsTalk #HeadsTalkPodcast #AFlyOnTheBoardroomWall #HTNeurotechSeries

Support the show

Follow, Support, Contact Heads Talk® - A Fly On The Boardroom Wall

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us